148 related articles for article (PubMed ID: 10072749)
1. The validity of male patients' self-reports regarding prostate cancer screening.
Jordan TR; Price JH; King KA; Masyk T; Bedell AW
Prev Med; 1999 Mar; 28(3):297-303. PubMed ID: 10072749
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997.
McDavid K; Melnik TA; Derderian H
Prev Med; 2000 Sep; 31(3):195-202. PubMed ID: 10964632
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing use of the prostate-specific antigen screening test in primary care.
Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
6. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
[TBL] [Abstract][Full Text] [Related]
8. Self-reported prostate cancer screening in Austria.
Vutuc C; Waldhoer T; Sevelda P; Micksche M; Haidinger G
J Med Screen; 2006; 13(3):148-51. PubMed ID: 17007656
[TBL] [Abstract][Full Text] [Related]
9. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer: what do general practitioners think?
Morris J; McNoe B
N Z Med J; 1997 May; 110(1044):178-82. PubMed ID: 9201202
[TBL] [Abstract][Full Text] [Related]
11. Percent free PSA as an additional measure in a prostate cancer screen.
Miele ME
Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
[TBL] [Abstract][Full Text] [Related]
12. Attitudes and practices of primary care physicians for prostate cancer screening.
Hoffman RM; Papenfuss MR; Buller DB; Moon TE
Am J Prev Med; 1996; 12(4):277-81. PubMed ID: 8874692
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of screening for prostate cancer: a nested case-control study.
Concato J; Wells CK; Horwitz RI; Penson D; Fincke G; Berlowitz DR; Froehlich G; Blake D; Vickers MA; Gehr GA; Raheb NH; Sullivan G; Peduzzi P
Arch Intern Med; 2006 Jan; 166(1):38-43. PubMed ID: 16401808
[TBL] [Abstract][Full Text] [Related]
14. Underutilization of digital rectal examination when screening for prostate cancer.
Murthy GD; Byron DP; Pasquale D
Arch Intern Med; 2004 Feb; 164(3):313-6. PubMed ID: 14769627
[TBL] [Abstract][Full Text] [Related]
15. Reliability of self-report versus chart-based prostate cancer, PSA, DRE and urinary symptoms.
Sayre EC; Bunting PS; Kopec JA
Can J Urol; 2009 Feb; 16(1):4463-71. PubMed ID: 19222884
[TBL] [Abstract][Full Text] [Related]
16. [Practice patterns of general practitioners in the Loire-Atlantique region and their patients' knowledge of prostate cancer screening].
Burin B; Bouchot O; Rigaud J
Prog Urol; 2006 Nov; 16(5):559-63. PubMed ID: 17175951
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
18. Predictors of prostate cancer screening among health fair participants.
Chiu BC; Anderson JR; Corbin D
Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
[TBL] [Abstract][Full Text] [Related]
20. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
Hosseini SY; Moharramzadeh M; Ghadian AR; Hooshyar H; Lashay AR; Safarinejad MR
Int J Urol; 2007 May; 14(5):406-11. PubMed ID: 17511722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
